<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-marinedrugs-17-00374" class="ref">
 <label class="label">92.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Parolini</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chiesa</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gong</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Caligari</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cortese</surname>
    <given-names class="given-names">M.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Koga</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Forte</surname>
    <given-names class="given-names">T.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rubin</surname>
    <given-names class="given-names">E.M.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Apolipoprotein A-I and the molecular variant apoA-I(Milano): Evaluation of the antiatherogenic effects in knock-in mouse model</article-title>
  <source class="source">Atherosclerosis</source>
  <year class="year">2005</year>
  <volume class="volume">183</volume>
  <fpage class="fpage">222</fpage>
  <lpage class="lpage">229</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.atherosclerosis.2005.03.008</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">16285990</pub-id>
 </element-citation>
</ref>
